Quick Answer
Skye Bioscience, Inc. reported Total Assets of $28.31 million for the year ending 2025.
- Skye Bioscience, Inc. showed a decrease of -61.1% in Total Assets from 2024 to 2025.
- This data is from Skye Bioscience, Inc.'s annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $134.4 thousand | Q3 2013: $129.0 thousand | Q4 2013: $145.7 thousand | Q1 2014: $140.8 thousand | Q2 2014: $122.7 thousand | Q3 2014: $167.6 thousand | Q3 2014: $1.13 million | Q1 2015: $468.7 thousand | Q2 2015: $820.8 thousand | Q3 2015: $4.54 million | Q1 2016: $2.35 million | Q2 2016: $1.08 million | Q3 2016: $692.1 thousand | Q1 2017: $617.4 thousand | Q2 2017: $484.0 thousand | Q3 2017: $343.0 thousand | Q1 2018: $3.16 million | Q2 2018: $2.04 million | Q3 2018: $1.17 million | Q1 2019: $4.72 million | Q2 2019: $3.08 million | Q3 2019: $1.73 million | Q1 2020: $673.0 thousand | Q2 2020: $227.2 thousand | Q3 2020: $4.35 million | Q1 2021: $5.40 million | Q2 2021: $5.49 million | Q3 2021: $11.69 million | Q1 2022: $7.21 million | Q2 2022: $4.97 million | Q3 2022: $2.87 million | Q1 2023: $4.59 million | Q2 2023: $2.24 million | Q3 2023: $15.60 million | Q1 2024: $94.84 million | Q2 2024: $87.26 million | Q3 2024: $81.54 million | Q1 2025: $64.79 million | Q2 2025: $52.16 million | Q3 2025: $41.32 million.
- Over the full 14 years of available data (2012 to 2025), Skye Bioscience, Inc.'s Total Assets has grown by 65,923.8%.
- Historical annual values: Fiscal year 2025: $28.31 million | Fiscal year 2024: $72.76 million | Fiscal year 2023: $11.94 million | Fiscal year 2022: $9.11 million | Fiscal year 2021: $9.86 million | Fiscal year 2020: $2.67 million | Fiscal year 2019: $2.00 million | Fiscal year 2018: $1.96 million | Fiscal year 2017: $557.2 thousand | Fiscal year 2016: $323.4 thousand | Fiscal year 2015: $3.51 million | Fiscal year 2014: $348.3 thousand | Fiscal year 2013: $145.7 thousand | Fiscal year 2012: $42.9 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: